Kolon Life Science Inc (102940)

Currency in KRW
33,300
+150(+0.45%)
Closed·
102940 Scorecard
Full Analysis
Suffers from weak gross profit margins
102940 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
32,90033,700
52 wk Range
16,78039,400
Key Statistics
Bid/Ask
33,200.00 / 33,300.00
Prev. Close
33,150
Open
33,150
Day's Range
32,900-33,700
52 wk Range
16,780-39,400
Volume
16.43K
Average Volume (3m)
51.96K
1-Year Change
41.7%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
102940 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Kolon Life Science Inc Company Profile

Kolon Life Science Inc., a biotechnology company, develops cell and gene therapy products. The company is developing KLS-2031, a product candidate in Phase 1 clinical trials for use in the treatment of neuropathic pain; and KLS-3021, a oncolytic viral therapy in pre-clinical development. It also provides active pharmaceutical ingredients and pharmaceutical intermediates; offers CDMO and CMO services; and supplies pyrithione antimicrobial for use in personal care and industrials products. The company was formerly known as Korea Tissuegene Asia, Ltd. and changed its name to Kolon Life Science Inc. in January 2006. Kolon Life Science Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

Employees
426

Compare 102940 to Peers and Sector

Metrics to compare
102940
Peers
Sector
Relationship
P/E Ratio
−5.3x−2.9x−0.5x
PEG Ratio
0.040.010.00
Price/Book
1.4x0.9x2.6x
Price / LTM Sales
2.5x0.8x3.2x
Upside (Analyst Target)
-39.1%41.4%
Fair Value Upside
Unlock14.9%6.0%Unlock

Earnings

Latest Release
May 15, 2025
EPS / Forecast
736.00 / --
Revenue / Forecast
44.83B / --
EPS Revisions
Last 90 days

102940 Income Statement

FAQ

What Stock Exchange Does Kolon Life Science Trade On?

Kolon Life Science is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Kolon Life Science?

The stock symbol for Kolon Life Science is "102940."

What Is the Kolon Life Science Market Cap?

As of today, Kolon Life Science market cap is 413.70B.

What Is Kolon Life Science's Earnings Per Share (TTM)?

The Kolon Life Science EPS (TTM) is -6,401.12.

From a Technical Analysis Perspective, Is 102940 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Kolon Life Science Stock Split?

Kolon Life Science has split 6 times.

How Many Employees Does Kolon Life Science Have?

Kolon Life Science has 426 employees.

What is the current trading status of Kolon Life Science (102940)?

As of 27 Jul 2025, Kolon Life Science (102940) is trading at a price of 33,300.00, with a previous close of 33,150.00. The stock has fluctuated within a day range of 32,900.00 to 33,700.00, while its 52-week range spans from 16,780.00 to 39,400.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.